Isocorydine

Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF) . Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC) [1].

Product Specifications

CAS Number

[475-67-2]

UNSPSC

12352005

Hazard Statement

H302, H312, H332

Target

Endogenous Metabolite

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

Neuroscience-Neuromodulation

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/isocorydine.html

Concentration

10mM

Purity

99.95

Solubility

DMSO : 20 mg/mL (ultrasonic)

Smiles

COC1=C2C3=C(C=C1OC)CCN(C)[C@@]3([H])CC4=CC=C(OC)C(O)=C24

Molecular Formula

C20H23NO4

Molecular Weight

341.40

Precautions

H302, H312, H332

References & Citations

[1]Pan JX, et al. Isocorydine suppresses doxorubicin-induced epithelial-mesenchymal transition via inhibition of ERK signaling pathways in hepatocellular carcinoma. Am J Cancer Res. 2018 Jan 1;8 (1) :154-164. eCollection 2018.